Always consult appropriate institutional guidelines and ensure protocols are approved by relevant ethical boards (e.g., IACUC, IRB)
Mechanism: GLP-1s can lower blood pressure, improve cholesterol levels, and reduce inflammation in the blood vessels, all of which contribute to their cardioprotective effects
Microdosing involves taking smaller, non-standard doses of these medications, with the goal of achieving weight loss with fewer side effects
DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
Many compounding pharmacies create versions of these drugs that may not meet the same safety and quality standards as FDA-approved products
Christopher Damman, Associate Professor of Gastroenterology, School of Medicine, University of Washington This article is republished from The Conversation under a Creative Commons license